Tumor necrosis factor-α-induced secretion of RANTES and interleukin-6 from human airway smooth-muscle cells modulation by cyclic adenosine monophosphate

American Journal of Respiratory Cell and Molecular Biology

Volumn 23, Issue 6, 2000, Pages 794-802

  Ammit, A J ^a   Hoffman, R K ^a   Amrani, Y ^a   Lazaar, A L ^a   Hay, D W P ^a   Torphy, T J ^a   Penn, R B ^a   Panettieri R A , Jr ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL ACTIVATION; CELL SECRETION; CELL STIMULATION; CYCLIC AMP; FORSKOLIN; GENETIC REGULATION; HUMAN CELL; INTERLEUKIN 6; MUSCLE CELL; NUCLEAR FACTOR; PROSTAGLANDIN; PROSTAGLANDIN E2; RANTES; T LYMPHOCYTE; TUMOR NECROSIS FACTOR ALPHA;

EID: 0034530199     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/ajrcmb.23.6.4184     Document Type: Article

References (35)

1. Cellular and molecular mechanisms regulating airway smooth muscle proliferation and cell adhesion molecule expression
2. T lymphocytes adhere to airway smooth muscle cells via integrins and CD44 and induce smooth muscle cell DNA synthesis
3. Tumor necrosis factor-α enhances mRNA expression and secretion of interleukin-6 in cultured human airway smooth muscle cells
4. Human airway smooth muscle cells express and release RANTES in response to T helper 1 cytokines
5. Adenosine-cyclic AMP pathways and cytokine expression
6. 1,4-cyclohexanecarboxylates: Potent and selective inhibitors of phosphodiesterase 4 for the treatment of asthma
7. Ariflo (SB 207499), a second generation phosphodiesterase inhibitor for the treatment of asthma and COPD: From concept to clinic
8. A human airway smooth muscle cell line that retains physiological responsiveness
9. 2AR-adenylyl eyelase pathway in human airway smooth muscle
10. CD40-mediated signal transduction in human airway smooth muscle
11. Up-regulation of ICAM-1 by cytokines in human tracheal smooth muscle cells involves an NF-κB-dependent signaling pathway that is only partially sensitive to dexamethasone
12. Inflammatory and contractile agents sensitize specific adenylyl cyclase isoforms in human airway smooth muscle
13. Increased MCP-1, RANTES, and MCP-1α in bronchoalvelolar lavage fluid of allergic asthmatic patients
14. Cytokines in symptomatic asthma airways
15. Airway remodeling in asthma
16. Regulation of RANTES and ICAM-1 expression in murine mesangial cells
17. Procaterol inhibits IL-1β- and TNF-α-mediated epithelial cell eosinophil chemotactic activity
18. 2-interferon/hepatocyte-stimulating factor/interleukin 6" promoter by cytokines, viruses, and second messenger agonists
19. Transcriptional regulation of the interleukin-6 gene in mesangial cells
20. 2-adrenoceptor in endotoxin-stimulated renal macrophage cells
21. MHC class II engagement in brain endothelial cells induces protein kinase A-dependent IL-6 secretion and phosphorylation of cAMP response element-binding protein
22. cAMP inhibition of interleukin-1-induced interleukin-6 production by human lung fibroblasts
23. Cyclic AMP signaling and gene regulation
24. Genomic organization and transcriptional regulation of the RANTES chemokine gene
25. Nuclear factor-κB potently up-regulates the promoter activity of RANTES, a chemokine that blocks HIV infection
26. Inhibition of microglial cell RANTES by IL-10 and TGF-beta
27. Stimulus-specific regulation of chemokine expression involves differential activation of the redox-responsive transcription factors AP-1 and NF-κB
28. Synergy between interferon-γ, and tumor necrosis factor-α in transcriptional activation is mediated by cooperation between signal transducer and activator of transcription 1 and nuclear factor κB
29. Triggering of the human interleukin-6 gene by interferon-γ, and tumour necrosis factor-α in monocytic cells involves cooperation between interferon regulatory factor-1, NF-κB, and Sp1 transcription factors
30. The nuclear factor-κB engages CBP/p300 and histone acetyltransferase activity for transcriptional activation of the IL-6 gene promoter
31. Activation and attenuation of transcription factor NF-κB in mouse glomerular mesangial cells in response to tumour necrosis factor-α, immunoglobulin G, and adenosine 3′:5′ cyclic monophosphate
32. Interleukin 1 and cyclic AMP induce immunoglobulin light-chain expression via activation of an NF-kappa B-like DNA binding protein
33. Activation of NF-κB in human myeloid cells
34. Multiple regulatory elements in the interleukin-6 gene mediate induction by prostaglandins, cAMP and lipopolysaccharides
35. Release of tumour necrosis factor by coronary smooth muscle: Activation of NF-κB and inhibition by elevated cyclic AMP